CORRESP Filing
AETHLON MEDICAL INC
Date: Aug. 29, 2025 · CIK: 0000882291 · Accession: 0001683168-25-006559
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289745
Letter
Aethlon Medical, Inc. 11555 Sorrento Valley Road, Suite 203
San Diego, CA 92121 (619) 941-0360
August 29, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Re: Aethlon Medical, Inc.
Registration Statement on Form S-1, as amended
File No. 333-289745
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Aethlon Medical, Inc., a Nevada corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended (File No. 333-289745), to become effective on Tuesday, September 2, 2025, at 5:01 p.m.., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Dennis Doucette, Esq. of Procopio, Cory, Hargreaves & Savitch LLP, to orally modify or withdraw this request for acceleration. Please contact Mr. Doucette at (858) 720-6322 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very Truly Yours,
Aethlon Medical, Inc.
Show Raw Text
CORRESP 1 filename1.htm Aethlon Medical, Inc. 11555 Sorrento Valley Road, Suite 203 San Diego, CA 92121 (619) 941-0360 August 29, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Aethlon Medical, Inc. Registration Statement on Form S-1, as amended File No. 333-289745 REQUEST FOR ACCELERATION OF EFFECTIVENESS Ladies and Gentleman: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Aethlon Medical, Inc., a Nevada corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended (File No. 333-289745), to become effective on Tuesday, September 2, 2025, at 5:01 p.m.., Eastern Time, or as soon thereafter as is practicable. The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. The Registrant hereby authorizes its counsel, Dennis Doucette, Esq. of Procopio, Cory, Hargreaves & Savitch LLP, to orally modify or withdraw this request for acceleration. Please contact Mr. Doucette at (858) 720-6322 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Very Truly Yours, Aethlon Medical, Inc. By: /s/ Jim Frakes Name: Jim Frakes Title: Chief Executive Officer